Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder

[1]  Adnan Kastrati,et al.  Variations of specific non-candidate genes and risk of myocardial infarction: a replication study. , 2011, International journal of cardiology.

[2]  Juntao Li,et al.  Identification of nigral dopaminergic neuron-enriched genes in adult rats , 2011, Neurobiology of Aging.

[3]  E. Warshaw,et al.  Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD. , 2010, Primary care companion to the Journal of clinical psychiatry.

[4]  S. Faraone,et al.  A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. , 2010, The Journal of clinical psychiatry.

[5]  R. Kass,et al.  Recent progress in congenital long QT syndrome , 2010, Current opinion in cardiology.

[6]  Joseph T. Glessner,et al.  Common Variants in HSPB7 and FRMD4B Associated With Advanced Heart Failure , 2010, Circulation. Cardiovascular genetics.

[7]  A. Lombardi,et al.  The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency , 2010, Journal of Thrombosis and Thrombolysis.

[8]  J. Buitelaar,et al.  Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis , 2010, European Child & Adolescent Psychiatry.

[9]  A. Marks,et al.  Ryanodine receptor channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.

[10]  Kari Stefansson,et al.  Several common variants modulate heart rate, PR interval and QRS duration , 2010, Nature Genetics.

[11]  Mark N. Wass,et al.  Genetic variation in SCN10A influences cardiac conduction , 2010, Nature Genetics.

[12]  J. Ferro,et al.  Kalirin: a novel genetic risk factor for ischemic stroke , 2010, Human Genetics.

[13]  A. Palmer,et al.  Polymorphisms in Dopamine Transporter (SLC6A3) are Associated with Stimulant Effects of d-Amphetamine: An Exploratory Pharmacogenetic Study Using Healthy Volunteers , 2010, Behavior genetics.

[14]  Christian Gieger,et al.  Genome-wide association study of PR interval , 2010, Nature Genetics.

[15]  G. D. De Keulenaer,et al.  The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy. , 2010, Circulation research.

[16]  Catherine A. Sugar,et al.  A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  Christiana Ruhrberg,et al.  Neuropilin ligands in vascular and neuronal patterning. , 2009, Biochemical Society transactions.

[18]  W. Kraus,et al.  Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13‐21 and Potential Effect Modification by Smoking , 2009, Annals of human genetics.

[19]  L. Cribbs,et al.  Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles , 2009, Molecular Pharmacology.

[20]  M. Shapiro.  An Ion Channel Hypothesis to Explain Divergent Cardiovascular Safety of Cyclooxygenase-2 Inhibitors: The Answer to a Hotly Debated Puzzle? , 2009, Molecular Pharmacology.

[21]  L. Almasy,et al.  Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. , 2009, Blood.

[22]  Kyung-Chul Choi,et al.  K+-dependent Na+/Ca2+ exchanger 3 is involved in renal active calcium transport and is differentially expressed in the mouse kidney. , 2009, American journal of physiology. Renal physiology.

[23]  J. Biederman,et al.  Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. , 2009, The Journal of pediatrics.

[24]  A. Reiner,et al.  Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study , 2009, Journal of thrombosis and haemostasis : JTH.

[25]  B. Leventhal,et al.  Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. , 2009, Journal of child and adolescent psychopharmacology.

[26]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[27]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[28]  C. Ting,et al.  Genome-Wide Association Study of Young-Onset Hypertension in the Han Chinese Population of Taiwan , 2009, PloS one.

[29]  T. Mikawa,et al.  FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation. , 2009, Developmental biology.

[30]  Thomas Lumley,et al.  Common variants at ten loci influence QT interval duration in the QTGEN Study , 2009, Nature Genetics.

[31]  Christian Gieger,et al.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study , 2009, Nature Genetics.

[32]  M. Fornage,et al.  Genome-Wide Identification of Allelic Expression in Hypertensive Rats , 2009, Circulation. Cardiovascular genetics.

[33]  T. Lumley,et al.  Gene Variants Associated With Ischemic Stroke: The Cardiovascular Health Study , 2009, Stroke.

[34]  B. Neale,et al.  Genome‐wide association study of response to methylphenidate in 187 children with attention‐deficit/hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  S. Faraone,et al.  Effect of stimulants on height and weight: a review of the literature. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  M. Pericak-Vance,et al.  Polymorphisms of the Tumor Suppressor Gene LSAMP are Associated with Left Main Coronary Artery Disease , 2008, Annals of human genetics.

[37]  N. Bresolin,et al.  Genetic polymorphisms for the study of multifactorial stroke , 2008, Human mutation.

[38]  S. Berger,et al.  Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and , 2008, Circulation.

[39]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[40]  L. Cribbs,et al.  Vascular KCNQ Potassium Channels as Novel Targets for the Control of Mesenteric Artery Constriction by Vasopressin, Based on Studies in Single Cells, Pressurized Arteries, and in Vivo Measurements of Mesenteric Vascular Resistance , 2008, Journal of Pharmacology and Experimental Therapeutics.

[41]  S. Berger,et al.  Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing , 2008 .

[42]  T. Arimura,et al.  Structural analysis of obscurin gene in hypertrophic cardiomyopathy. , 2007, Biochemical and biophysical research communications.

[43]  Stephen V Faraone,et al.  Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. , 2007, The Journal of clinical psychiatry.

[44]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[45]  M. Schwake,et al.  Molecular expression and pharmacological identification of a role for Kv7 channels in murine vascular reactivity , 2007, British journal of pharmacology.

[46]  J. Haines,et al.  Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. , 2007, American journal of human genetics.

[47]  T. Spencer.  Pharmacology of Adult ADHD with Stimulants , 2007, CNS Spectrums.

[48]  S. Faraone,et al.  Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[49]  J. Swanson,et al.  Pharmacogenetics of methylphenidate response in preschoolers with ADHD. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  Yanfen Jiang,et al.  Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle. , 2006, American journal of physiology. Heart and circulatory physiology.

[51]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[52]  T. E. Sweeney,et al.  Impaired flow-induced dilation in mesenteric resistance arteries from receptor protein tyrosine phosphatase-mu-deficient mice. , 2005, American journal of physiology. Heart and circulatory physiology.

[53]  Harriet de Wit,et al.  Dopamine Transporter Gene Associated with Diminished Subjective Response to Amphetamine , 2005, Neuropsychopharmacology.

[54]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[55]  Hideyuki Yamamoto,et al.  The mouse sino‐atrial node expresses both the type 2 and type 3 Ca2+ release channels/ryanodine receptors , 2003, FEBS letters.

[56]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[57]  H. Ehmke,et al.  A polycystin-2-like large conductance cation channel in rat left ventricular myocytes. , 2003, Cardiovascular research.

[58]  N. Samani.  Genome scans for hypertension and blood pressure regulation. , 2003, American journal of hypertension.

[59]  M. Rapport,et al.  Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects. , 2002, Clinical psychology review.

[60]  Nirbhay N. Singh,et al.  Psychopharmacological Intervention I , 1990 .

[61]  H. Yoshida,et al.  Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. , 2010, American journal of hypertension.

[62]  Manuel A. R. Ferreira,et al.  Genetics and population analysis A multivariate test of association , 2009 .

[63]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[64]  D. Levy,et al.  Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study , 2007, BMC Medical Genetics.

[65]  Qiong Yang,et al.  Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study , 2007, BMC medical genetics.

[66]  J. Sorof,et al.  Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial , 2005, Pediatric Nephrology.

[67]  Ekow Oppon,et al.  Bmc Medical Genetics Arrhythmogenic Right Ventricular Cardiomyopathy Type 6 (arvc6): Support for the Locus Assignment, Narrowing of the Critical Region and Mutation Screening of Three Candidate Genes , 2005 .

[68]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .